DALLAS--(BUSINESS WIRE)--HemoBioTech (OTCBB: HMBT, www.hemobiotech.com), a biopharmaceutical company focused on developing and commercializing the first viable human blood substitute, will present at the EQUITIES 57th Anniversary Spring Conference to be held at the Princeton Club on April 18th, in New York City.
